Who expects preliminary clinical trials within three weeks of two key therapies

China News Agency, Brussels, Feb 20 (Xinhua) - Geneva news: World Health Organization director general Tan Desai announced on Feb 20 that the current two key therapies to fight against the new coronavirus are expected to reach preliminary clinical trial results within three weeks He also confirmed that the WHO Expert Group under investigation in China includes US experts At a regular press conference held at WHO headquarters in Geneva on the same day, Tan Desai said that the blueprint of who research and development listed the anti AIDS drugs lopinavir / ritonavir (Chinese trade name "klitschke") and the antiviral drug remdesivir as the key therapies to fight against the new coronavirus, and looked forward to the conclusion of clinical trials of these two therapies As a result, "we expect preliminary results in three weeks." According to public reports, at present, lopinavir / litonavir and ridcivir are both in Wuhan for clinical research For example, the novel coronavirus pneumonia clinic in Wuhan was launched in early February at the golden Yin Tan Hospital in Wuhan to evaluate the efficacy and safety of the new drug that has not yet been listed China also has China novel coronavirus pneumonia experts working in China Tan Desai also said that the Chinese experts will work together to find answers to some questions, such as the severity of new crown pneumonia, the infection of the new crown virus, and the role of China's epidemic prevention and control measures.